Cargando…
Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
BACKGROUND: Enhancer of zeste homologue 2 (EZH2) is a polycomb group (PcG) family protein. Acting as a histone methyltransferase it plays crucial roles in maintaining epigenetic stem cell signature, while its deregulation leads to tumor development. EZH2 overexpression is commonly associated with po...
Autores principales: | Changchien, Yi-Che, Tátrai, Péter, Papp, Gergő, Sápi, Johanna, Fónyad, László, Szendrői, Miklós, Pápai, Zsuzsanna, Sápi, Zoltán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494513/ https://www.ncbi.nlm.nih.gov/pubmed/23110793 http://dx.doi.org/10.1186/1479-5876-10-216 |
Ejemplares similares
-
Correlation between DNA ploidy, metaphase high-resolution comparative genomic hybridization results and clinical outcome of synovial sarcoma
por: Balogh, Zsófia, et al.
Publicado: (2011) -
A Challenging Case of Metastatic Intra-Abdominal Synovial Sarcoma with Unusual Immunophenotype and Its Differential Diagnosis
por: Changchien, Yi-Che, et al.
Publicado: (2012) -
Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma
por: Mihály, Dóra, et al.
Publicado: (2018) -
The Activation of PDGFRβ on Mononuclear Stromal/Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment. An Immunohistochemical Study of Five Cases
por: Antal, Imre, et al.
Publicado: (2022) -
Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2012)